ATLASMyriad Genetics (MYGN) earnings date: Nov 4, 2026
Myriad Genetics (MYGN) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$0.25.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MYGN
| Last price | $5.92 (-6.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Myriad Genetics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Myriad Genetics reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Myriad Genetics. You can switch it off at any time.
Alert me before MYGN reportsFree to start. Creating an account takes under a minute.
Notify me when Myriad Genetics reports
MYGN earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.25 |
| Last report | Jul 30, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -66.3% |
| Average move around a report | ±17.4% (last 4) |
| Sector | Healthcare · Diagnostics & Research |
Myriad Genetics earnings history: last 4 reports
Myriad Genetics last reported on Jul 30, 2026: EPS of -$0.25 against an estimate of -$0.06 (-316.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | -$0.06 | -$0.25 | -316.7% | Miss | -43.3% |
| Jul 8, 2026 | $0.04 | $0.05 | +25.0% | Beat | +4.1% |
| May 5, 2026 | $2.88 | $3.30 | +14.6% | Beat | -16.8% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +5.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MYGN
See the fair value, the probability range and the earnings history of Myriad Genetics on its ATLAS page.
Myriad Genetics (MYGN) stock analysisPlans from €3.99 a month.
Myriad Genetics earnings: frequently asked questions
When does Myriad Genetics (MYGN) report earnings?
Myriad Genetics is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MYGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.25 per share (USD). Estimates can change before the report.
How often does MYGN beat earnings estimates?
Of its last 4 reports with a recorded result, Myriad Genetics beat the EPS estimate 3 times; the average surprise was -66.3%. Past results do not predict the next one.
How much does MYGN move around earnings?
Over its last 4 reports the stock moved an average of 17.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Myriad Genetics beat earnings estimates last quarter?
Myriad Genetics last reported on Jul 30, 2026: EPS of -$0.25 against an estimate of -$0.06 (-316.7% surprise), a miss.
How much does MYGN usually move in a day?
On a normal trading day the ATLAS model puts MYGN’s one-day range at about ±5.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer